Actively Recruiting
Evaluating High-Tech Rehabilitation Versus Traditional Therapy for Adults with Chronic Neuromuscular Diseases in a Pragmatic Randomized Trial
Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-11-04
60
Participants Needed
7
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether high-tech rehabilitation methods using robotic systems, virtual reality, and balance platforms are not worse than traditional rehabilitation in reducing fatigue and improving balance, motor skills, and quality of life in adults with chronic neuromuscular diseases such as Amyotrophic Lateral Sclerosis, Chronic Inflammatory Demyelinating Polyneuropathy, and Charcot-Marie-Tooth disease. This interventional, randomized, pragmatic trial compares these advanced technology treatments to conventional methods. Participants assigned to the robotic treatment group will receive cognitive and motor exercises via virtual reality devices, balance and posture training on stabilometric platforms, aerobic exercises on robotic treadmills, and usual physiotherapy. The control group will undergo traditional rehabilitation following clinical care standards. The study timeline includes treatment sessions with ongoing assessments over 60 days. During the study, participants will have evaluations at multiple time points including baseline and days 15, 30, 45, and 60 to measure fatigue severity, walking ability, balance, motor function, cognitive engagement, and quality of life using various scales and tests. Researchers will monitor changes in these outcomes to assess the effects of the rehabilitation methods. The trial is expected to complete by December 2026.
CONDITIONS
Brief Title
High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project
Research Team
C
Christian Lunetta, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here